Literature DB >> 9084382

Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers.

J C Carroll1, A J Reid, C A Woodward, J A Permaul-Woods, S Domb, G Ryan, S Arbitman, B Fallis, J Kilthei.   

Abstract

OBJECTIVE: To determine the practices, knowledge and opinions of health care providers regarding a prenatal genetic screening program in Ontario.
DESIGN: Cross-sectional self-reported survey.
SETTING: Ontario. PARTICIPANTS: Random sample of 2000 family physicians, all 565 obstetricians and all 62 registered midwives in the province. Among subjects who were eligible (those providing antenatal care or attending births) the response rates were 91% (778/851), 76% (273/359) and 78% (46/59) respectively. MAIN OUTCOME MEASURES: Which patients were offered maternal serum screening (MSS), how results were being communicated, knowledge of the test's sensitivity, likes and dislikes about MSS and recommendations regarding the program.
RESULTS: Most (97%) of respondents stated that they were offering MSS to the pregnant women in their practices; 88% were offering it routinely to all pregnant women (87% of the family physicians, 90% of the obstetricians and 100% of the midwives). Most (92%) of the respondents stated that they communicate positive results to their patients personally as soon as they are received; 23% did so for negative results. The respondents correctly identified the initial positive rate but underestimated the false-positive rate. About one-third did not respond to these knowledge questions. Of those who gave feedback on the screening program, 50% recommended that it not be changed, 29% suggested that it be changed, and 22% recommended that it be scrapped.
CONCLUSIONS: Participation in the Ontario Maternal Serum Screening Program by health care providers has been good, although knowledge about MSS is far from ideal. Many providers have reservations about the program. In light of concerns raised about the high false-positive rate and the anxiety such results generate in pregnant women, there is a need for more education of providers and patients and a better understanding of women's experiences with genetic screening.

Entities:  

Mesh:

Year:  1997        PMID: 9084382      PMCID: PMC1227040     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Maternity Care Guidelines checklist. To assist physicians in implementing CPGs.

Authors:  C M Kirkham; S Grzybowski
Journal:  Can Fam Physician       Date:  1999-03       Impact factor: 3.275

2.  Information and decision support needs of parents considering amniocentesis: interviews with pregnant women and health professionals.

Authors:  Marie-Anne Durand; Mareike Stiel; Jacky Boivin; Glyn Elwyn
Journal:  Health Expect       Date:  2010-06       Impact factor: 3.377

3.  Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study.

Authors:  Robin Z Hayeems; Michael Campitelli; Xiaomu Ma; Tianhua Huang; Mark Walker; Astrid Guttmann
Journal:  CMAJ Open       Date:  2015-04-02

Review 4.  Maternal decisions regarding prenatal diagnosis: rational choices or sensible decisions?

Authors:  Karen L Lawson; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2007-03

5.  Maternal serum screening in Newfoundland and Labrador: do attitude and knowledge affect physicians' practice?

Authors:  Jonathan Cavanagh; Maria Mathews
Journal:  Can Fam Physician       Date:  2006-10       Impact factor: 3.275

6.  Maternity care and maternal serum screening. Do male and female family physicians care for women differently?

Authors:  C A Woodward; J C Carroll; G Ryan; A J Reid; J A Permaul-Woods; S Arbitman; S B Domb; B Fallis; J Kilthei
Journal:  Can Fam Physician       Date:  1997-06       Impact factor: 3.275

7.  Preventing neural tube defects. Survey of preconceptional use of folic acid.

Authors:  I M Neimanis; J M Paterson; E Bain
Journal:  Can Fam Physician       Date:  1999-07       Impact factor: 3.275

8.  Going the distance: the influence of practice location on the Ontario Maternal Serum Screening Program.

Authors:  J A Permaul-Woods; J C Carroll; A J Reid; C A Woodward; G Ryan; S Domb; S Arbitman; B Fallis; J Kilthei
Journal:  CMAJ       Date:  1999-08-24       Impact factor: 8.262

9.  Prenatal diagnosis for paediatricians.

Authors:  Anne Summers
Journal:  Paediatr Child Health       Date:  2003-01       Impact factor: 2.253

10.  Psychological outcomes following maternal serum screening: a cohort study.

Authors:  V Goel; R Glazier; A Summers; S Holzapfel
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.